Qube Research & Technologies Ltd - RANI THERAPEUTICS HLDGS INC ownership

RANI THERAPEUTICS HLDGS INC's ticker is and the CUSIP is 753018100. A total of 38 filers reported holding RANI THERAPEUTICS HLDGS INC in Q1 2024. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of RANI THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q2 2024$12
+33.3%
30.0%0.00%
Q1 2024$9
-10.0%
30.0%0.00%
Q4 2023$10
+42.9%
30.0%0.00%
Q3 2023$7
-100.0%
3
-100.0%
0.00%
Q1 2023$102,72019,9070.00%
Other shareholders
RANI THERAPEUTICS HLDGS INC shareholders Q1 2024
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 493,584$2,912,1462.01%
LASRY MARC 62,887$602,4570.94%
Alpha Square Group S LLC 101,603$599,4580.26%
Alphabet Inc. 510,128$3,009,7550.18%
TPB WEALTH ADVISORS 48,129$2840.15%
UNITED SERVICES AUTOMOBILE ASSOCIATION 481,300$2,840,0000.06%
ISLAY CAPITAL MANAGEMENT, LLC 9,611$56,7050.06%
Lafayette Investments 19,893$117,3690.03%
Canton Hathaway, LLC 14,600$860.03%
MOTCO 48,129$283,9610.02%
View complete list of RANI THERAPEUTICS HLDGS INC shareholders